These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 25435182)

  • 21. Formulation and process strategies to minimize coat damage for compaction of coated pellets in a rotary tablet press: A mechanistic view.
    Xu M; Heng PWS; Liew CV
    Int J Pharm; 2016 Feb; 499(1-2):29-37. PubMed ID: 26748363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MUPS Tableting-Comparison between Crospovidone and Microcrystalline Cellulose Core Pellets.
    Thio DR; Heng PWS; Chan LW
    Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of drug release from coated pellets based on isomalt, sugar, and microcrystalline cellulose inert cores.
    Kállai N; Luhn O; Dredán J; Kovács K; Lengyel M; Antal I
    AAPS PharmSciTech; 2010 Mar; 11(1):383-91. PubMed ID: 20237965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and in vitro evaluation of ketoprofen extended release pellets using powder layering technique in a rotary centrifugal granulator.
    Pai R; Pai A; Srivastava B; Kohli K
    Comb Chem High Throughput Screen; 2011 Feb; 14(2):138-45. PubMed ID: 21118082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation of sustained release matrix pellets by melt agglomeration in the fluidized bed: influence of formulation variables and modelling of agglomerate growth.
    Pauli-Bruns A; Knop K; Lippold BC
    Eur J Pharm Biopharm; 2010 Mar; 74(3):503-12. PubMed ID: 20026401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a tamsulosin hydrochloride controlled-release capsule consisting of two different coated pellets.
    Zhang X; Tang X; Yang R
    Drug Dev Ind Pharm; 2009 Jan; 35(1):26-33. PubMed ID: 18686088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of zero-order release kinetics from acetaminophen-layered Suglet® pellets, Wurster-coated with plasticized Aquacoat® ECD (ethyl cellulose dispersion).
    Kaur S; Sivasankaran S; Wambolt E; Jonnalagadda S
    Int J Pharm; 2020 Jan; 573():118873. PubMed ID: 31765772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained-release pellets prepared by combination of wax matrices and double-layer coatings for extremely water-soluble drugs.
    Tian L; Zhang Y; Tang X
    Drug Dev Ind Pharm; 2008 Jun; 34(6):569-76. PubMed ID: 18568906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic effect of polyethylene glycol and superdisintegrant on dissolution rate enhancement of simvastatin in pellet formulation.
    Afrasiabi Garekani H; Aftabi SF; Nia FF; Javidi M; Nokhodchi A; Sadeghi F
    Pharm Dev Technol; 2019 Jul; 24(6):720-728. PubMed ID: 30776937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Approaches to developing fast release pellets via wet extrusion-spheronization.
    Xia Y; Shi CY; Fang JG; Wang WQ
    Pharm Dev Technol; 2018 Jun; 23(5):432-441. PubMed ID: 27882815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formulation of lipid bearing pellets as a delivery system for poorly soluble drugs.
    Chopra S; Venkatesan N; Betageri GV
    Int J Pharm; 2013 Mar; 446(1-2):136-44. PubMed ID: 23422274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple response optimisation of processing and formulation parameters of pH sensitive sustained release pellets of capecitabine for targeting colon.
    Pandey S; Swamy SMV; Gupta A; Koli A; Patel S; Maulvi F; Vyas B
    J Microencapsul; 2018 May; 35(3):259-271. PubMed ID: 29659317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An evaluation of microcrystalline cellulose attributes affecting compaction-induced pellet coat damage through a multi-faceted analysis.
    Thio DR; Aguilera Q; Yeoh JKX; Sia Heng PW; Chan LW
    Int J Pharm; 2023 Aug; 643():123245. PubMed ID: 37467819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and Quality evaluation of sustained release pellets of eperisone HCl.
    Jawed SH; Muhammad IN; Qazi F; Shoaib MH; Arshad HM; Siddiqui T
    Pak J Pharm Sci; 2021 Jan; 34(1(Supplementary)):225-235. PubMed ID: 34275846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Novel Approach for Dry Powder Coating of Pellets with Ethylcellulose. Part II: Evaluation of Caffeine Release.
    Albertini B; Melegari C; Bertoni S; Dolci LS; Passerini N
    AAPS PharmSciTech; 2018 Apr; 19(3):1426-1436. PubMed ID: 29441468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sustained-release alginate-chitosan pellets prepared by melt pelletization technique.
    Wong TW; Nurulaini H
    Drug Dev Ind Pharm; 2012 Dec; 38(12):1417-27. PubMed ID: 22309449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control of drug release by incorporation of sorbitol or mannitol in microcrystalline-cellulose-based pellets prepared by extrusion-spheronization.
    Goyanes A; Souto C; Martínez-Pacheco R
    Pharm Dev Technol; 2010 Dec; 15(6):626-35. PubMed ID: 20148708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Ceolus™ microcrystalline cellulose grades for the direct compression of enteric-coated pellets.
    Kucera SU; DiNunzio JC; Kaneko N; McGinity JW
    Drug Dev Ind Pharm; 2012 Mar; 38(3):341-50. PubMed ID: 21870908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of starting material particle size on pellet surface roughness.
    Sarkar S; Ang BH; Liew CV
    AAPS PharmSciTech; 2014 Feb; 15(1):131-9. PubMed ID: 24198222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.